1-3 of 3
Claudia Polloni, MD
Close
Sort by
Journal Articles

Thalidomide-Dexamethasone vs Interferon-α-Dexamethasone as Maintenance Treatment after ThaDD Induction for Multiple Myeloma (MM): Final Analysis of a Prospective, Randomized Study.

Massimo Offidani, MD, Claudia Polloni, MD, Laura Corvatta, MD, Maria-Novella Piersantelli, MD, Piero Galieni, MD, Giuseppe Visani, MD, Francesco Alesiani, MD, Massimo Catarini, MD, Marino Brunori, MD, Maurizio Burattini, MD, Riccardo Centurioni, MD, Mario Ferranti, MD, Luciano Giuliodori, MD, Marco Candela, MD, Anna Mele, MD, Monica Marconi, MD, Pietro Leoni, PhD
Journal: Blood
Blood (2007) 110 (11): 532.
https://doi.org/10.1182/blood.V110.11.532.532
Published: 2007
Journal Articles

ThaDD-V Treatment for Patients with Relapsed/Refractory Multiple Myeloma: A Feasibility/Activity Study.

Massimo Offidani, MD, Claudia Polloni, MD, Laura Corvatta, MD, Maria-Novella Piersantelli, MD, Anna Mele, MD, Massimo Catarini, MD, Marino Brunori, MD, Mario Ferranti, MD, Barbara Amoroso, MD, Pietro Leoni, PhD
Journal: Blood
Blood (2007) 110 (11): 2729.
https://doi.org/10.1182/blood.V110.11.2729.2729
Published: 2007
Journal Articles

Thalidomide-Dexamethasone (Thal-dex) vs Interferon-α-Dexamethasone (IFN-dex) as Maintenance Treatment after ThaDD Induction for Multiple Myeloma (MM): First Analysis of a Prospective Randomized Study.

Massimo Offidani, MD, Laura Corvatta, MD, Claudia Polloni, MD, Maria-Novella Piersantelli, MD, Piero Galieni, MD, Giuseppe Visani, MD, Francesco Alesiani, MD, Massimo Catarini, MD, Marino Brunori, MD, Maurizio Burattini, MD, Riccardo Centurioni, MD, Mario Ferranti, MD, Luciano Giuliodori, MD, Marco Candela, MD, Monica Marconi, MD, Pietro Leoni, PhD
Journal: Blood
Blood (2006) 108 (11): 3566.
https://doi.org/10.1182/blood.V108.11.3566.3566
Published: 2006